Thesan Pharmaceuticals
Preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€178—267m (Dealroom.co estimates Feb 2014.)
San Clemente California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$16.0m | Series A | ||
$49.0m | Series B | ||
N/A | Series B | ||
Total Funding | €59.1m |
Related Content
Recent News about Thesan Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.